Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹2,934 Cr
up ₹178 Cr vs Jul 2024
- Stocks held
- 28
- down 1 vs Jul 2024
- Top 10 weight
- 66.8%
- of the portfolio in its ten largest
- Cash & debt
- 5.6%
- cash, money market and debt
- Moves this month
- 0 in · 1 out
- added to 10, trimmed 5
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In August 2024 it disclosed 28 stocks worth ₹2,934 Cr, up ₹178 Cr from Jul 2024. Its largest positions were Sun Pharmaceutical Industries Limited (11.6%), Suven Pharmaceuticals Limited (10.1%), Lupin Limited (8.3%); the ten largest together made up 66.8% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 67.9% of its equity. Cash and debt stood at 5.6%. Compared with Jul 2024 the fund entered 0 new stocks and exited 1.
Against 229 other Sectoral / Thematic funds
Concentration
92%
Top-10 weight is higher than 92% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
75%
Holds more cash than 75% of peers
What these mean: concentration · cash
Holdings in August 2024
Download CSVEvery line the fund disclosed, with the change against Jul 2024. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 11.64% | down 0.06 pts | ₹342 Cr | up ₹19.2 Cr | Added |
| Suven Pharmaceuticals Limited | 10.08% | down 0.39 pts | ₹296 Cr | up ₹7.2 Cr | Added |
| Lupin Limited | 8.34% | up 0.76 pts | ₹245 Cr | up ₹35.9 Cr | Added |
| Cipla Limited | 7.82% | up 0.05 pts | ₹229 Cr | up ₹15.3 Cr | Added |
| IPCA Laboratories Limited | 7.57% | down 0.04 pts | ₹222 Cr | up ₹12.3 Cr | Added |
| Cash, TREPS & receivables | 5.64% | up 2.32 pts | ₹165 Cr | up ₹73.9 Cr | Added |
| Alembic Pharmaceuticals Limited | 5.14% | down 0.95 pts | ₹151 Cr | down ₹17.1 Cr | Trimmed |
| Globus Medical Inc | 5.09% | down <0.01 pts | ₹149 Cr | up ₹9 Cr | Added |
| Apollo Hospitals Enterprise Limited | 4.40% | down 0.07 pts | ₹129 Cr | up ₹5.8 Cr | Added |
| Concord Biotech Limited | 3.55% | down 0.17 pts | ₹104 Cr | up ₹1.6 Cr | Added |
| Vijaya Diagnostic Centre Limited | 3.17% | up 0.25 pts | ₹93 Cr | up ₹12.4 Cr | Added |
| Kovai Medical Center and Hospital Limited | 3.04% | up 0.33 pts | ₹89.1 Cr | up ₹14.4 Cr | Added |
| Pfizer Limited | 2.93% | up 1.37 pts | ₹86.1 Cr | up ₹42.9 Cr | Added |
| Procter & Gamble Health Limited | 2.82% | down 0.20 pts | ₹82.8 Cr | down ₹52 L | Trimmed |
| Indoco Remedies Limited | 2.75% | up 0.09 pts | ₹80.8 Cr | up ₹7.3 Cr | Added |
| Intuitive Surgical Inc | 2.64% | up 0.11 pts | ₹77.5 Cr | up ₹7.7 Cr | Added |
| Illumina Inc | 2.42% | up 0.47 pts | ₹71 Cr | up ₹17.2 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 1.76% | up <0.01 pts | ₹51.7 Cr | up ₹3.2 Cr | Added |
| Aarti Drugs Limited | 1.47% | up 0.10 pts | ₹43 Cr | up ₹5.3 Cr | Added |
| Unichem Laboratories Limited | 1.45% | down 0.07 pts | ₹42.6 Cr | up ₹78 L | Added |
| Narayana Hrudayalaya Limited | 1.29% | down 0.07 pts | ₹37.8 Cr | up ₹38 L | Added |
| Abbott Laboratories | 1.02% | up 0.01 pts | ₹30 Cr | up ₹2 Cr | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 0.80% | down 0.07 pts | ₹23.4 Cr | down ₹48 L | Trimmed |
| Alkem Laboratories Limited | 0.79% | up 0.07 pts | ₹23 Cr | up ₹3.2 Cr | Added |
| Emcure Pharmaceuticals Limited | 0.78% | up 0.13 pts | ₹22.9 Cr | up ₹5 Cr | Added |
| Gland Pharma Limited | 0.62% | down 0.15 pts | ₹18.2 Cr | down ₹3 Cr | Trimmed |
| MedPlus Health Services Limited | 0.44% | down 0.03 pts | ₹13 Cr | down ₹1 L | Held |
| Jupiter Life Line Hospitals Limited | 0.44% | down 0.03 pts | ₹12.9 Cr | up ₹1 L | Held |
| Thyrocare Technologies Limited | 0.07% | down <0.01 pts | ₹2.1 Cr | up ₹11 L | Added |
| Grail Inc | 0.04% | down 0.01 pts | ₹1 Cr | down ₹9 L | Trimmed |
What changed, Jul 2024 to Aug 2024
New New positions (0)
None.
Exited Exited (1)
- Zydus Lifesciences Limitedwas 3.7% · ₹102 Cr
Added Biggest additions
- Pfizer Limitedup ₹42.9 Cr (+1.37% pts)
- Lupin Limitedup ₹35.9 Cr (+0.76% pts)
- Sun Pharmaceutical Industries Limitedup ₹19.2 Cr (−0.06% pts)
- Illumina Incup ₹17.2 Cr (+0.47% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2024, the weight rose most in Healthcare Services (+1.3 pts) and Healthcare Equipment & Supplies (+0.3 pts), and fell most in Pharmaceuticals & Biotechnology (−1.8 pts).
- Healthcare Services14.6% → 15.9%+1.3 pts
- Healthcare Equipment & Supplies8.0% → 8.3%+0.3 pts
- Pharmaceuticals5.4% → 5.6%+0.2 pts
- Pharmaceuticals & Biotechnology69.7% → 67.9%−1.8 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2021 | Aug 2023 | Feb 2024 | May 2024 | Jul 2024 | Aug 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 58.9% | 74.6% | 70.8% | 68.5% | 69.7% | 67.9% |
| Healthcare Services | 25.9% | 11.7% | 14.0% | 15.3% | 14.6% | 15.9% |
| Healthcare Equipment & Supplies | 5.9% | 5.0% | 7.1% | 8.3% | 8.0% | 8.3% |
| Pharmaceuticals | 6.8% | 5.7% | 5.7% | 5.6% | 5.4% | 5.6% |
| Insurance | 2.5% | 2.0% | 1.8% | 1.7% | 1.8% | 1.9% |
| Retailing | — | 1.0% | 0.6% | 0.6% | 0.5% | 0.5% |
Allocation in Aug 2024change vs Jul 2024
- Pharmaceuticals & Biotechnology (13)67.9%▼ 1.8 pts
- Healthcare Services (8)15.9%▲ 1.3 pts
- Healthcare Equipment & Supplies (2)8.3%▲ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Aug 2024
5.6%
▲ 2.3 pts vs Jul 2024
- Cash alone
- 5.6%
- cash and net receivables
- A year earlier
- 3.2%
- Aug 2023 · now ▲ 2.5 pts
- Last 12 months
- 0.9% – 5.6%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.